EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Follow‐up for human papillomavirus‐related oropharynx cancer concentrated on unequal symptom change ( FOCUS ): Prospective patient‐reported outcome collection

Donna M Edwards, Laila A Gharzai iD, Weilin Wang, Charles Mayo, Krithika Suresh, Matthew Schipper, Joseph R Evans, Kelly Malloy, Steven B Chinn, Mark Prince iD, Matthew Spector, Andrew Shuman iD und 10 weitere

Head & Neck · 2024

DOI: 10.1002/hed.27778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Donna M Edwards und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Patient Reported Outcome Measures, Papillomavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Livestrong Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post‐treatment surveillance recommendations for oropharyngeal cancer do not vary with p16 status despite the differences in outcomes. The optimal algorithm personalizing follow‐up for these patients remains undefined. Here, we evaluate the feasibility and utility of incorporating electronic patient‐reported outcomes (ePROs) and circulating tumor DNA (ctDNA) into routine surveillance for patients treated for p16+ oropharynx cancer.

Methods

A prospective registry was developed in which ePROs and ctDNA were incorporated into routine surveillance among patients with oropharynx cancer. ePROs were emailed monthly for 1 year and blood HPV ctDNA testing was performed every 3–6 months. The primary objective was to assess patient compliance with ePRO‐based surveillance with adequate compliance defined as ≥85% of patients completing monthly ePROs. Sensitivity, specificity, and positive/negative predictive values to detect recurrence were calculated for ePROs, HPV ctDNA, or the combination.

Results

Of 122 patients who initially expressed interest, 76 completed the electronic consent process and 44/76 (58%) were compliant with monthly surveys over 1 year; thus adequate compliance was not achieved. Technical difficulties associated with ePRO receipt through email largely limited participation. Provider feedback was significantly associated with heightened ePRO compliance. One hundred and six patients had ctDNA testing with a mean number of three tests per patient. Sensitivity to detect recurrence was 75% for the combination of ePROs and ctDNA.

Conclusion

Despite lower than anticipated compliance with ePROs, our findings show promise for incorporation of HPV ctDNA into surveillance paradigms for HPV‐related oropharynx cancer with suggestions of methods to optimize ePRO formats for personalized surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oropharyngeal NeoplasmsPatient Reported Outcome MeasuresPapillomavirus InfectionsHumansMaleFemaleProspective StudiesMiddle AgedAgedFollow-Up StudiesCirculating Tumor DNARegistriesFeasibility StudiesAdultPatient ComplianceNeoplasm Recurrence, LocalHuman Papillomavirus Viruses

Stichwörter der Autor:innen

cancer of oropharynxfollow‐up carepatient‐reported outcome measures

Substanzen

Circulating Tumor DNA

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA.
  • Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Medicine, Hematology-Oncology, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Laila A Gharzai, Mark Prince, Andrew Shuman, Paul L Swiecicki, Michelle L Mierzwa

Förderung

  • Livestrong Foundation

Zitieren

APA

Edwards, D. M., Gharzai, L. A., Wang, W., Mayo, C., Suresh, K., Schipper, M., Evans, J. R., Malloy, K., Chinn, S. B., Prince, M., Spector, M., Shuman, A., Stucken, C., Swiecicki, P. L., Worden, F., Jarema, J., Henderson, C., Kovach, A., Brenner, C., …, & Casper, K. (2024). Follow‐up for human papillomavirus‐related oropharynx cancer concentrated on unequal symptom change ( FOCUS ): Prospective patient‐reported outcome collection. Head & Neck. https://doi.org/10.1002/hed.27778

Vancouver

Edwards DM, Gharzai LA, Wang W, Mayo C, Suresh K, Schipper M, et al. Follow‐up for human papillomavirus‐related oropharynx cancer concentrated on unequal symptom change ( FOCUS ): Prospective patient‐reported outcome collection. Head & Neck. 2024. doi:10.1002/hed.27778

BibTeX
@article{Edwards2024,
  author = {Edwards, Donna M and Gharzai, Laila A and Wang, Weilin and Mayo, Charles and Suresh, Krithika and Schipper, Matthew and Evans, Joseph R and Malloy, Kelly and Chinn, Steven B and Prince, Mark and Spector, Matthew and Shuman, Andrew and Stucken, Chaz and Swiecicki, Paul L and Worden, Francis and Jarema, Jennifer and Henderson, Caitlin and Kovach, Amanda and Brenner, Chad and Shah, Jennifer L and Mierzwa, Michelle L and Casper, Keith},
  title = {Follow‐up for human papillomavirus‐related oropharynx cancer concentrated on unequal symptom change ( FOCUS ): Prospective patient‐reported outcome collection},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27778}
}
Kostenlos starten →